Cited by 861Sleep and related disordersCancer survivorship and careSleep and Work-Related Fatigue

Insomnia in the Context of Cancer: A Review of a Neglected Problem

Savard, Josée, Morin, Charles M.·2001·Journal of Clinical Oncology

Abstract

ABSTRACT: This article reviews the evidence on the diagnosis, epidemiology, etiology, and treatment of insomnia in the context of cancer and proposes several areas for future research. Clinical and diagnostic features of insomnia are described and prevalence estimates of insomnia complaints in cancer patients are summarized. Then, potential etiologic factors (ie, predisposing, precipitating, and perpetuating factors) and consequences of insomnia (ie, psychologic, behavioral, and health impact) in the context of cancer are discussed. Finally, pharmacologic and psychologic treatments previously shown effective to treat insomnia in healthy individuals are discussed as valuable treatment options for cancer patients as well. Because long-term use of hypnotic medications is associated with some risks (eg, dependence), it is argued that psychologic interventions (eg, stimulus control, sleep restriction, cognitive therapy) are the treatment of choice for sleep disturbances in the context of cancer, especially when it has reached a chronic course. However, the efficacy of these treatments has yet to be verified specifically in cancer patients.

Integrity signals

Registry

Crossref · 10.1200/jco.2001.19.3.895

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Insomnia is a prevalent complaint linked to cancer and its treatments, affecting between 29% and 64% of cancer survivors months or years after treatment completion.

    “Insomnia emerges as a prevalent complaint linked to cancer and its treatments, and tends to persist, affecting between 29% to 64% of can -cer survivors months or years after treatment completion. 4-6”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Savard, J., & Morin, C. M.
Affiliations
Université Laval (CA)
Venue
Journal of Clinical Oncology
Published
2001-02-01
Volume
19
Issue
3
Pages
895-908
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2112502628
Cited by
861
References
103
Citations by year
2026: 30 · 2025: 49 · 2024: 50 · 2023: 48 · 2022: 43 · 2021: 56 · 2020: 40 · 2019: 37 · 2018: 35 · 2017: 35 · 2016: 38 · 2015: 34 · 2014: 42 · 2013: 40 · 2012: 44
FWCI
3.70
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
Keywords
insomnia, cancer patients, sleep disorders, insomnia prevalence, insomnia etiology, insomnia treatment, hypnotics, hypnotic dependence, cognitive behavioral therapy, stimulus control, sleep restriction, chronic insomnia
MeSH terms
Humans, Sleep Initiation and Maintenance Disorders, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review